Literature DB >> 277918

Cycloheximide resistance can be mediated through either ribosomal subunit.

C A Sutton, M Ares, R L Hallberg.   

Abstract

Two cycloheximide-resistant mutants of Tetrahymena thermophila were analyzed to determine the site of their cycloheximide resistance. The mutations in both strains had been previously shown to be genetically dominant and located at separate loci (denoted Chx-A and Chx-B). Strains carrying these mutations were readily distinguished by the extent to which they were resistant to the drug. The homozygous double mutant was more resistant than either single mutant. Cell-free extracts of wild type and of the three mutant strains, assayed for protein synthetic activity by both runoff of natural mRNA and poly(U)-dependent phenylalanine polymerization, demonstrated that in vitro the mutants were all more resistant than the wild type. Further fractionation of the cell-free systems into ribosomes and supernates localized cycloheximide resistance to the ribosome for both Chx-A and Chx-B homozygotes. Ribosome dissociation and pairwise subunit mixing in the in vitro system indicated that ribosome resistance was conferred by the 60S subunit from one strain whereas resistance in the other strain was mediated through the 40S subunit. This was further confirmed by reconstruction of all four cycloheximide-resistance "phenotypes" by mixing ribosomal subunits from appropriate strains. This finding suggests that the mechanisms by which these mutations confer resistance to cycloheximide are different.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 277918      PMCID: PMC392733          DOI: 10.1073/pnas.75.7.3158

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  A ribosome-dependent GTPase from yeast distinct from elongation factor 2.

Authors:  L Skogerson; E Wakatama
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

2.  Streptomycin resistance; a genetically recessive mutation.

Authors:  J LEDERBERG
Journal:  J Bacteriol       Date:  1951-05       Impact factor: 3.490

3.  Initiation and elongation of protein synthesis in growing cells: differential inhibition by cycloheximide and emetine.

Authors:  N L Oleinick
Journal:  Arch Biochem Biophys       Date:  1977-07       Impact factor: 4.013

4.  Genetics and biochemistry of cycloheximide resistance in Physarum polycephalum.

Authors:  F B Haugli; W F Dove; A Jimenez
Journal:  Mol Gen Genet       Date:  1972

5.  Role of ribosomes in cycloheximide resistance of Neurospora mutants.

Authors:  M Pongratz; W Klingmüller
Journal:  Mol Gen Genet       Date:  1973-08-28

6.  Alpha and beta globin messenger ribonucleic acid. Different amounts and rates of initiation of translation.

Authors:  H F Lodish
Journal:  J Biol Chem       Date:  1971-12-10       Impact factor: 5.157

7.  Selective inhibition of protein synthesis initiation in Saccharomyces cerevisiae by low concentrations of cycloheximide.

Authors:  T G Cooper; J Bossinger
Journal:  J Biol Chem       Date:  1976-11-25       Impact factor: 5.157

8.  A cycloheximide sensitivity factor from yeast required for N-acetylphenylalanylpuromycin formation.

Authors:  U Somasundaran; L Skogerson
Journal:  Biochemistry       Date:  1976-11-02       Impact factor: 3.162

9.  The molecular basis of emetine resistance in Chinese hamster ovary cells: alteration in the 40S ribosomal subunit.

Authors:  R S Gupta; L Siminovitch
Journal:  Cell       Date:  1977-01       Impact factor: 41.582

10.  Genetics of cycloheximide resistance in Tetrahymena.

Authors:  L K Bleyman; P J Bruns
Journal:  Genetics       Date:  1977-10       Impact factor: 4.562

View more
  16 in total

1.  Identification and characterization of small molecules that inhibit intracellular toxin transport.

Authors:  Jose B Saenz; Teresa A Doggett; David B Haslam
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

2.  Transformation of Tetrahymena to cycloheximide resistance with a ribosomal protein gene through sequence replacement.

Authors:  M C Yao; C H Yao
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

3.  The cytoplasmic ribosomes of Chlamydomonas reinhardtii: characterization of antibiotic sensitivity and cycloheximide-resistant mutants.

Authors:  G H Fleming; J E Boynton; N W Gillham
Journal:  Mol Gen Genet       Date:  1987-12

4.  Resistance against cycloheximide in cell lines from Chinese hamster and human cells is conferred by the large subunit of cytoplasmic ribosomes.

Authors:  H Pöche; S Zakrzewski; K H Nierhaus
Journal:  Mol Gen Genet       Date:  1979-09

5.  No heat shock protein synthesis is required for induced thermostabilization of translational machinery.

Authors:  R L Hallberg
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

6.  Properties of the translocatable tetracycline-resistance element Tn10 in Escherichia coli and bacteriophage lambda.

Authors:  N Kleckner; D F Barker; D G Ross; D Botstein
Journal:  Genetics       Date:  1978-11       Impact factor: 4.562

7.  Effect of heat shock on ribosome structure: appearance of a new ribosome-associated protein.

Authors:  T W McMullin; R L Hallberg
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

8.  Cycloheximide-resistance in Chinese hamster ovary cells and human fibroblast cells. Cytogenetic and biochemical characterization.

Authors:  H Pöche; K H Nierhaus; S Zakrzewski
Journal:  Hum Genet       Date:  1979-09       Impact factor: 4.132

9.  Core formation and the acquisition of fusion competence are linked during secretory granule maturation in Tetrahymena.

Authors:  Grant R Bowman; Nels C Elde; Garry Morgan; Mark Winey; Aaron P Turkewitz
Journal:  Traffic       Date:  2005-04       Impact factor: 6.215

10.  Mechanisms of action of aminoglycoside antibiotics in eucaryotic protein synthesis.

Authors:  D C Eustice; J M Wilhelm
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.